Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. - Schadendorf,D.; Ugurel,S.; Schuler-Thurner,B.; Nestle,FO.; Enk,A.; Brocker,EB.; Grabbe,S.; Rittgen,W.; Edler,L.; Sucker,A.; Zimpfer-Rechner,C.; Berger,T.; et al. (Ann Oncol, 2006)